BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20546781)

  • 1. Cardiovascular risk factors regulate the expression of vascular endothelin receptors.
    Xu CB; Sun Y; Edvinsson L
    Pharmacol Ther; 2010 Aug; 127(2):148-55. PubMed ID: 20546781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-soluble smoke particles upregulate vascular smooth muscle ETB receptors via activation of mitogen-activating protein kinases and NF-kappaB pathways.
    Xu CB; Zheng JP; Zhang W; Zhang Y; Edvinsson L
    Toxicol Sci; 2008 Dec; 106(2):546-55. PubMed ID: 18718921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin-1 synthesis and endothelin B receptor expression in human coronary artery smooth muscle cells and monocyte-derived macrophages is up-regulated by low density lipoproteins.
    Haug C; Schmid-Kotsas A; Zorn U; Schuett S; Gross HJ; Gruenert A; Bachem MG
    J Mol Cell Cardiol; 2001 Sep; 33(9):1701-12. PubMed ID: 11549348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of proteinase-activated receptors in the vascular physiology and pathophysiology.
    Hirano K
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):27-36. PubMed ID: 17095716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of endothelin receptors by nitric oxide in cultured rat vascular smooth muscle cells.
    Redmond EM; Cahill PA; Hodges R; Zhang S; Sitzmann JV
    J Cell Physiol; 1996 Mar; 166(3):469-79. PubMed ID: 8600150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial stiffness, endothelial function and novel pharmacological approaches.
    Wilkinson IB; McEniery CM
    Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):795-9. PubMed ID: 15566396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PKC and MAPK signalling pathways regulate vascular endothelin receptor expression.
    Nilsson D; Wackenfors A; Gustafsson L; Ugander M; Ingemansson R; Edvinsson L; Malmsjö M
    Eur J Pharmacol; 2008 Feb; 580(1-2):190-200. PubMed ID: 18031734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endotoxin induces toll-like receptor 4 expression in vascular smooth muscle cells via NADPH oxidase activation and mitogen-activated protein kinase signaling pathways.
    Lin FY; Chen YH; Tasi JS; Chen JW; Yang TL; Wang HJ; Li CY; Chen YL; Lin SJ
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2630-7. PubMed ID: 17008589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-kappaB signaling mediates vascular smooth muscle endothelin type B receptor expression in resistance arteries.
    Zheng JP; Zhang Y; Edvinsson L; Hjalt T; Xu CB
    Eur J Pharmacol; 2010 Jul; 637(1-3):148-54. PubMed ID: 20399772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arterial wall-determined risk factors to vascular diseases: a nonhuman primate model.
    Wang XL; Wang J; Shi Q; Carey KD; VandeBerg JL
    Cell Biochem Biophys; 2004; 40(3):371-88. PubMed ID: 15211033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin, endothelin receptors, and endothelin antagonists.
    Lüscher TF
    Curr Opin Nephrol Hypertens; 1994 Jan; 3(1):92-8. PubMed ID: 7850417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative stimulation of the vascular Endothelin-1 axis in vitro and ex vivo by infection with Chlamydia pneumoniae.
    Kern JM; Maass V; Rupp J; Maass M
    Thromb Haemost; 2009 Oct; 102(4):743-53. PubMed ID: 19806261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular signatures determining coronary artery and saphenous vein smooth muscle cell phenotypes: distinct responses to stimuli.
    Deng DX; Spin JM; Tsalenko A; Vailaya A; Ben-Dor A; Yakhini Z; Tsao P; Bruhn L; Quertermous T
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1058-65. PubMed ID: 16456091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin--role in vascular disease.
    Abraham D; Dashwood M
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v23-4. PubMed ID: 18784133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of alpha-adrenoceptor expression by lipid-soluble smoke particles through transcriptional factor nuclear factor-kappaB pathway.
    Zhang W; Cao YX; He JY; Xu CB
    Basic Clin Pharmacol Toxicol; 2007 Dec; 101(6):401-6. PubMed ID: 18028103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naringin inhibits matrix metalloproteinase-9 expression and AKT phosphorylation in tumor necrosis factor-alpha-induced vascular smooth muscle cells.
    Lee EJ; Kim DI; Kim WJ; Moon SK
    Mol Nutr Food Res; 2009 Dec; 53(12):1582-91. PubMed ID: 19810018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RHO SIGNALING in vascular diseases.
    Seasholtz TM; Brown JH
    Mol Interv; 2004 Dec; 4(6):348-57. PubMed ID: 15616164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium channels expressed in vascular smooth muscle.
    Marks AR
    Circulation; 1992 Dec; 86(6 Suppl):III61-7. PubMed ID: 1330365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redox signaling in hypertension.
    Paravicini TM; Touyz RM
    Cardiovasc Res; 2006 Jul; 71(2):247-58. PubMed ID: 16765337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.